We are live on ! Find out more
ASPX

AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX

Delisted

ASPX was delisted on the 4th of May, 2015.

Back to rankings

47 hedge funds and large institutions have $271M invested in AUSPEX PHARMACEUTICALS INC COM STK (DE) in 2014 Q1 according to their latest regulatory filings, with 47 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
47
Holders Change
+47
Holders Change %
–
% of All Funds
1.36%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
47
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$58.3M
2
DM
Deerfield Management
New York
+$53.4M
3
Millennium Management
Millennium Management
New York
+$24.1M
4
Franklin Resources
Franklin Resources
California
+$13.2M
5
KCM
Kingdon Capital Management
New York
+$10.8M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$996K +$870K +32,365 New
TCIM
27
TIAA CREF Investment Management
New York
$924K +$807K +30,034 New
SKK
28
Shepherd Kaplan Krochuk
Massachusetts
$913K +$798K +29,681 New
ICAP
29
Independence Capital Asset Partners
Colorado
$877K +$766K +28,499 New
BIM
30
BlackRock Investment Management
Delaware
$708K +$619K +23,031 New
California State Teachers Retirement System (CalSTRS)
31
California State Teachers Retirement System (CalSTRS)
California
$449K +$392K +14,600 New
HAMF
32
Hatteras Alternative Mutual Funds
North Carolina
$410K +$358K +13,317 New
TA
33
Teachers Advisors
New York
$353K +$308K +11,470 New
MLICM
34
Metropolitan Life Insurance Company (MetLife)
New York
$300K +$262K +9,745 New
NSEDCP
35
NJ State Employees Deferred Compensation Plan
New Jersey
$204K +$177K +6,600 New
TAM
36
Tocqueville Asset Management
New York
$200K +$175K +6,500 New
Creative Planning
37
Creative Planning
Kansas
$123K +$107K +4,000 New
NFA
38
Nationwide Fund Advisors
Ohio
$122K +$107K +3,971 New
Deutsche Bank
39
Deutsche Bank
Germany
$81K +$70.9K +2,640 New
BA
40
BlackRock Advisors
Delaware
$69K +$60.6K +2,256 New
TRCT
41
Tower Research Capital (TRC)
New York
$62K +$53.7K +2,000 New
Citigroup
42
Citigroup
New York
$44K +$38.9K +1,446 New
U
43
UBS
Switzerland
$21K +$18.5K +689 New
LTFS
44
Ladenburg Thalmann Financial Services
Florida
$15K +$13.4K +500 New
BlackRock
45
BlackRock
New York
$7K +$5.86K +218 New
Barclays
46
Barclays
United Kingdom
$7K +$5.91K +220 New
MAA
47
Managed Account Advisors
New Jersey
$7K +$5.99K +223 New
1
2

ASPX Hedge Fund Activity: Q1 2014 in Review

47 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) for Q1 2014, worth a combined $271M.

Buyers outnumbered sellers: 47 funds opened new ASPX positions and 0 closed out — a net gain of 47 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $58.3M.

  • 47 institutional investors held AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) as of Q1 2014, up from 0 in Q4 2013.
  • Funds reported $271M of AUSPEX PHARMACEUTICALS INC COM STK (DE) stock for Q1 2014.
  • 47 funds opened new AUSPEX PHARMACEUTICALS INC COM STK (DE) positions in Q1 2014 and 0 closed out, a net change of +47 holders.
  • The largest AUSPEX PHARMACEUTICALS INC COM STK (DE) buyer in Q1 2014 was Fidelity Investments, an estimated $58.3M added.

Based on aggregated 13F filings for Q1 2014.